Article Figures & Data
Figures
- Figure 1.
Value distribution and medians of serum levels of soluble cell death receptor sFAS (A), macrophage migration-inhibitory factor (MIF) (B), soluble intercellular adhesion molecule (sICAM) (C) and plasminogen activator inhibitor 1 (PAI-1) (D) in healthy persons, patients with benign breast diseases, patients with locally confined breast cancer and patients with metastasized breast cancer.
- Figure 2.
Receiver operating characteristic (ROC) curves for the discrimination between patients with locally confined breast cancer and healthy controls (A), as well as between patients with metastatic breast cancer and all other controls (B).
- Figure 3.
Receiver operating characteristic (ROC) curves for the discrimination between patients with response and those with no response to neoadjuvant chemotherapy. Setting 1: NC versus CR+PR (A); Setting 2: NC+PR versus CR (B).
